Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | XNCR | ELVN | ||
| Company | Ars Pharmaceuticals Inc | Xencor Inc | Enliven Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.28 | 15.74 | 17.84 | ||
| High | 11.32 | 16.04 | 17.88 | ||
| Low | 10.77 | 15.22 | 16.48 | ||
| Latest | 11.03 | 15.47 | 16.53 | ||
| Change | -0.33 | -0.50 | -1.40 | ||
| % Change | -2.90% | -3.13% | -7.81% | ||
| Volume | 1,274,300 | 506,225 | 889,495 | ||
| 20-Day Average Volume | 1,819,135 | 830,051 | 840,525 | ||
| Previous Close | 11.36 | 15.97 | 17.93 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.11 | 16.71 | 19.18 | ||
| 20-Day Raw Stochastic | 86.69% | 7.20% | 12.17% | ||
| 20-Day Relative Strength | 57.61 | 49.39 | 39.90 | ||
| Weighted Alpha | -11.29 | -1.94 | -26.08 | ||
| Today's Opinion | 24% Sell | 80% Buy | 40% Sell | ||
| Previous Opinion | 24% Sell | 80% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.47% since 12/16/25 | -6.53% since 12/16/25 | -2.25% since 12/16/25 | ||
| Low | 9.78 on 12/18/25 | 15.22 on 12/23/25 | 15.71 on 12/17/25 | ||
| High | 11.50 on 12/22/25 | 16.89 on 12/17/25 | 18.05 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +45.32% since 11/21/25 | -2.52% since 11/21/25 | -24.00% since 11/21/25 | ||
| Low | 7.56 on 11/24/25 | 15.22 on 12/23/25 | 15.71 on 12/17/25 | ||
| High | 11.50 on 12/22/25 | 18.69 on 12/05/25 | 22.85 on 11/24/25 | ||
| 3-Month | |||||
| %Chg | +10.97% since 09/23/25 | +49.90% since 09/23/25 | -13.86% since 09/23/25 | ||
| Low | 6.66 on 11/21/25 | 10.24 on 09/25/25 | 15.71 on 12/17/25 | ||
| High | 11.70 on 10/10/25 | 18.69 on 12/05/25 | 24.64 on 10/31/25 | ||
| 6-Month | |||||
| %Chg | -33.43% since 06/23/25 | +83.95% since 06/23/25 | -18.53% since 06/23/25 | ||
| Low | 6.66 on 11/21/25 | 6.92 on 08/11/25 | 15.71 on 12/17/25 | ||
| High | 18.90 on 06/27/25 | 18.69 on 12/05/25 | 24.64 on 10/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,122,925 | 1,140,418 | 1,064,092 | ||
| Shares Outstanding, K | 98,849 | 71,410 | 59,347 | ||
| Annual Sales | 89,150,000 | 110,490,000 | 0 | ||
| Annual Net Income | 8,000,000 | -232,620,000 | -89,020,000 | ||
| Last Quarter Sales | 32,500,000 | 21,000,000 | 0 | ||
| Last Quarter Net Income | -51,150,000 | -6,030,000 | -20,150,000 | ||
| 60-Month Beta | 0.82 | 0.96 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 11/10/25 | -0.08 on 11/05/25 | -0.32 on 11/12/25 | ||
| Latest Earnings Date | 03/19/26 | 02/26/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||